Mehdi Navid Adham, MD | |
8100 S Walker Ave Bldg A, Oklahoma City, OK 73139-9475 | |
(405) 632-4468 | |
(405) 632-0436 |
Full Name | Mehdi Navid Adham |
---|---|
Gender | Male |
Speciality | Hand Surgery |
Experience | 47 Years |
Location | 8100 S Walker Ave Bldg A, Oklahoma City, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205836491 | NPI | - | NPPES |
13913 | Other | OK | MEDICAL LICENSE |
Facility Name | Location | Facility Type |
---|---|---|
Oklahoma Center For Orthopaedic & Multi-sp | Oklahoma city, OK | Hospital |
Integris Southwest Medical Center | Oklahoma city, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Southwest Orthopaedic Specialists Pllc | 9931180346 | 22 |
News Archive
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that Bayer Yakuhin, Ltd., Osaka, Japan, has submitted an application to the Ministry of Health, Labor and Welfare (MHLW) in Japan for marketing authorization for EYLEA, also known as VEGF Trap-Eye, for the treatment of the neovascular form of age-related macular degeneration (wet AMD).
Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.
Omthera Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for the marketing and sale of Epanova™ for the treatment for patients with severe hypertriglyceridemia (triglyceride levels greater than or equal to 500mg/dL).
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the launch of its new journal, The Journal of Applied Laboratory Medicine: An AACC Publication.
› Verified 7 days ago
Entity Name | Southwest Orthopaedic Specialists Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669559720 PECOS PAC ID: 9931180346 Enrollment ID: O20040601000087 |
News Archive
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that Bayer Yakuhin, Ltd., Osaka, Japan, has submitted an application to the Ministry of Health, Labor and Welfare (MHLW) in Japan for marketing authorization for EYLEA, also known as VEGF Trap-Eye, for the treatment of the neovascular form of age-related macular degeneration (wet AMD).
Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.
Omthera Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for the marketing and sale of Epanova™ for the treatment for patients with severe hypertriglyceridemia (triglyceride levels greater than or equal to 500mg/dL).
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the launch of its new journal, The Journal of Applied Laboratory Medicine: An AACC Publication.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Mehdi Navid Adham, MD 8100 S Walker Ave, Blgd A, Oklahoma City, OK 73139-9402 Ph: (405) 632-4468 | Mehdi Navid Adham, MD 8100 S Walker Ave Bldg A, Oklahoma City, OK 73139-9475 Ph: (405) 632-4468 |
News Archive
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that Bayer Yakuhin, Ltd., Osaka, Japan, has submitted an application to the Ministry of Health, Labor and Welfare (MHLW) in Japan for marketing authorization for EYLEA, also known as VEGF Trap-Eye, for the treatment of the neovascular form of age-related macular degeneration (wet AMD).
Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.
Omthera Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for the marketing and sale of Epanova™ for the treatment for patients with severe hypertriglyceridemia (triglyceride levels greater than or equal to 500mg/dL).
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the launch of its new journal, The Journal of Applied Laboratory Medicine: An AACC Publication.
› Verified 7 days ago
Ashok Krishnamurthy, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6718 S Western Ave, Oklahoma City, OK 73139 Phone: 405-602-1053 Fax: 405-602-1059 | |
Dr. Anureet Bajaj, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 8106 N May Ave, Ste. B, Oklahoma City, OK 73120 Phone: 405-810-8448 Fax: 405-810-9755 | |
Dr. Tim Rodney Love, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11101 Hefner Pointe Dr Ste 104, Oklahoma City, OK 73120 Phone: 405-751-5683 Fax: 405-751-9500 | |
Stephen Cole Gauthier, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 6516 N Olie Ave, Suite E, Oklahoma City, OK 73116 Phone: 405-286-5606 Fax: 405-286-5607 | |
Dr. Joseph Warner Hayhurst, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 701 Ne 10th St, Suite 16, Oklahoma City, OK 73104 Phone: 405-232-1144 | |
Dr. Rachel Hein, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5401 N Portland Ave Ste 600, Oklahoma City, OK 73112 Phone: 405-604-8485 Fax: 405-604-8486 |